Copyright
©The Author(s) 2023.
World J Gastroenterol. Aug 28, 2023; 29(32): 4860-4872
Published online Aug 28, 2023. doi: 10.3748/wjg.v29.i32.4860
Published online Aug 28, 2023. doi: 10.3748/wjg.v29.i32.4860
Table 1 List of primers used in this study
| Name | Forward primers | Reverse primers |
| 16s | AGGATCAAGGTTTAAGGATT | CTGGAGACTAAGCCCTCC |
| MdaB | AGGCTATGAACACGCTCAAGAAGTG | TTTCACAATCCAAGGCTCTCCCATC |
| SodB | AAGCGACTGCCTTAAGCGATGAG | TCCAGCCAGAGCCAAACAAAGTG |
Table 2 Gene affected by linolenic acid-metronidazole treatment
| Gene | Name | Log2 fold change | Description | Enrichment pathway |
| MdaB | HPG27_RS03065 | 4.962 | Flavodoxin family protein | Oxidoreductase activity |
| SodB | HPG27_RS05265 | 4.2287 | Superoxide dismutase | Oxidoreductase activity |
- Citation: Zhou WT, Dai YY, Liao LJ, Yang SX, Chen H, Huang L, Zhao JL, Huang YQ. Linolenic acid-metronidazole inhibits the growth of Helicobacter pylori through oxidation. World J Gastroenterol 2023; 29(32): 4860-4872
- URL: https://www.wjgnet.com/1007-9327/full/v29/i32/4860.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i32.4860